Citi Depositary Receipt Services Year-End 2017 Report

DR ACCESS PRODUCTS ABOUT CITI DEPOSITARY RECEIPT SERVICES INTERNATIONAL INVESTING TRENDS REGIONAL TRENDS GLOBAL DR TRENDS Issuer Country Industry 2 USD Value (in Millions) Adaptimmune Therapeutics plc* 5 UK Pharmaceuticals, Biotechnology $108 BioLineRX Israel Pharmaceuticals, Biotechnology $29 Summit Therapeutics plc UK Pharmaceuticals, Biotechnology $20 Akari Therapeutics Plc UK Pharmaceuticals, Biotechnology $17 Sequans Communications SA France Technology Hardware & Equipment $14 BiondVax Pharmaceuticals Ltd Israel Pharmaceuticals, Biotechnology $10 Can-Fite BioPharma Israel Pharmaceutical $5 Prima BioMed Limited Australia Health Care Equipment & Services $5 Medigus Ltd Israel Health Care Equipment & Services $3 XTL Biopharmaceuticals Ltd. Israel Pharmaceuticals, Biotechnology $3 Grand Total $6,240 17 Citi Depositary Receipt Services Year-End 2017 Report